Omada Health is trading 5.49% up at $22.68 after announcing updated long-term financial targets at its inaugural Investor Day on September 10, 2026.

  • Management targets annual revenue growth of at least 20%, an 80% non-GAAP gross margin, and a 30% adjusted EBITDA margin.
  • The Investor Day webcast begins at 1:00 p.m. Eastern Time.
  • Broader markets are lower after hotter-than-expected producer inflation, making the company-specific announcement the clearest explanation for the gain.